![](https://www.pdfsearch.io/img/47dff78ec052cc713cc6aba71e9f5c94.jpg) Date: 2017-06-26 08:58:58
| | GMI-1271, a Potent E-Selectin Antagonist, in Combination with Chemotherapy in Relapsed/Refractory AML: A Novel, Well-Tolerated Regimen with a High Remission Rate Daniel J. DeAngelo*1, Brian A. Jonas2, Jane L. Liesveld3, Add to Reading ListSource URL: glycomimetics.comDownload Document from Source Website File Size: 729,11 KBShare Document on Facebook
|